MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences

    C.L. Dietiker, N.B. Galifianakis, M. Katz, S.L. Heath (San Francisco, CA, USA)

    Objective: To describe the development of palliative care clinics for patients with advanced Parkinson's disease (PD) in two diverse settings with a qualitative focus on…
  • 2016 International Congress

    The value of preference-based measures of quality of life in people with Parkinson’s: A systematic review

    Y. Xin, E. McIntosh (Glasgow, United Kingdom)

    Objective: To systematically review and assess the use and value of preference-based quality of life (QoL) measures in Parkinson's. Background: Preference-based QoL measures are used…
  • 2016 International Congress

    Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease

    C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…
  • 2016 International Congress

    A comparison study of health-related quality of life between female and male patients with Parkinson’s disease

    B. Donmez Colakoglu, T. Kahraman, E. Goz, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

    Objective: To investigate the effect of gender difference on health-related quality of life in patients with Parkinson's disease (PD). Background: PD has a negative impact…
  • 2016 International Congress

    Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

    Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…
  • 2016 International Congress

    Implications of direct and indirect costs in health-related quality of life in Parkinson’s disease: A cross-sectional study in Mexico

    M. Rodríguez-Violante, A. Jorge de Saráchaga, A. Cervantes-Arriaga, H. Soto-Molina, M. Márquez-Cruz (Mexico City, Mexico)

    Objective: To evaluate the association of direct and indirect costs of Parkinson's disease (PD) and health-related quality of life (HRQoL) in a Mexican population. Background:…
  • 2016 International Congress

    The care needs project: Understanding the experience of people with Parkinson’s in institutional care and understanding the care needs of people with Parkinson’s

    A. Hand, R.W. Walker, W.K. Gray, L.L. Oates (North Shields, United Kingdom)

    Objective: To look at predictors to care home placement for people with Parkinson's (PD) along with the experience of those already in care and identify…
  • 2016 International Congress

    Influence of vibration to quality of life of patients with Parkinson’s disease

    V. Rashidov (Tashkent, Uzbekistan)

    Objective: To study influence of vibration at the Qizil tosh marble manufacture in Tashkent City. Background: A marble is a small spherical toy usually made…
  • 2016 International Congress

    Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment

    G. Amorelli, L.F. Vasconcellos, M. Spitz, L.F. Fraga (Rio de Janeiro, Brazil)

    Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…
  • 2016 International Congress

    Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru

    A. Vishnevetsky, M.A. Inca-Martinez, M. Illanes-Manrique, M. Cornejo-Olivas (Lima, Peru)

    Objective: To quantitatively and qualitatively explore the determinants of quality of life (QOL) in Huntington's Disease (HD) patients and their caregivers in Peru. Background: HD…
  • « Previous Page
  • 1
  • …
  • 1396
  • 1397
  • 1398
  • 1399
  • 1400
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley